Short tuberculosis treatment for mild spinal TB
Treatments studied
Part of Bones, joints & muscles, Infections clinical trials.
This study tests a shorter course of tuberculosis (TB) medicines for people with mild TB in the spine. The goal is to see if a shorter treatment can work just as well and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 12 years old.
- You have been diagnosed with mild tuberculosis in the spine.
- You are generally able to care for yourself (score of 60 or higher on the Karnofsky scale).
- You have not taken more than 5 days of TB medicines in the past 6 months.
- You are not pregnant or breastfeeding, and you are willing to use contraception if you can become pregnant.
- You do not have spinal tumors, mental health conditions that affect decision-making, or known drug allergies to the study medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a shorter treatment using the drug rifampicin is as good as the usual longer treatment for people with less severe tuberculosis (TB). If you join, you'd get a shorter course of pills, which might be more convenient and have fewer side effects.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study tests a shorter treatment for a type of TB that is resistant to rifampicin (a common TB medicine) but still sensitive to isoniazid. It aims to see if this shorter regimen is as effective as the current longer one, potentially making treatment less burdensome for patients.
This study tests if a shorter course of tuberculosis (TB) medicine works as well as the current longer treatment for children. If successful, it means fewer days of medicine and fewer side effects for kids.
This study tests a shorter, more intensive treatment for tuberculosis that affects the brain. It may help reduce side effects while still curing the infection.
Hear when a new Mild Spinal Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.